Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Imaging01:14

Brain Imaging

662
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
662

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.

Brain communications·2026
Same author

Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study.

Lancet (London, England)·2026
Same author

Association of neighborhood deprivation with Alzheimer's Disease pathology, brain structure, and cognition by race and ethnicity, sex, and APOE ε4 status.

medRxiv : the preprint server for health sciences·2026
Same author

Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Peripheral immune profiling in frontotemporal dementia.

Brain communications·2026

Related Experiment Video

Updated: Jan 15, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.4K

Neuroimaging in psychiatric disorders.

Joseph C Masdeu1

  • 1Section on Integrative Neuroimaging, Intramural Research Program, National Institutes of Health (NIH/NIMH-CBDB), Bethesda, Maryland 20892-1365, USA. masdeu@nih.gov

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|January 29, 2011
PubMed
Summary

Neuroimaging aids psychiatric diagnosis and medication development by detecting lesions and differentiating disorders. Molecular neuroimaging, including PET and SPECT, identifies drug targets and optimizes clinical trials.

More Related Videos

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
10:43

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

15.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

Related Experiment Videos

Last Updated: Jan 15, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.4K
Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
10:43

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

15.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

Area of Science:

  • Psychiatry
  • Neuroimaging
  • Medical Diagnostics

Background:

  • Neuroimaging is crucial in psychiatry for diagnosing disorders and developing novel therapeutics.
  • It aids in identifying structural brain abnormalities linked to psychosis.
  • Neuroimaging helps distinguish between depression, neurodegenerative diseases, and brain tumors.

Purpose of the Study:

  • To highlight the role of neuroimaging in psychiatric diagnosis and drug development.
  • To explain the application of functional neuroimaging in therapeutic target identification.
  • To underscore the utility of neuroimaging in patient selection for clinical trials.

Main Methods:

  • Utilizing structural neuroimaging to detect lesions causing psychosis.
  • Employing functional neuroimaging techniques, primarily molecular imaging (PET, SPECT).
  • Applying neuroimaging for differential diagnosis of psychiatric and neurological conditions.

Main Results:

  • Neuroimaging effectively detects structural lesions and aids in differential diagnosis.
  • Molecular neuroimaging (PET, SPECT) identifies key therapeutic targets.
  • Functional neuroimaging guides optimal drug dosing and patient stratification for trials.

Conclusions:

  • Neuroimaging is indispensable for advancing psychiatric care and pharmaceutical research.
  • Molecular neuroimaging offers precise tools for drug development and clinical trial design.
  • The diagnostic and therapeutic applications of neuroimaging significantly impact patient outcomes.